Company Profiles

driven by the PitchBook Platform

Light Sciences Oncology

Light Sciences Oncology
1994 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$350k LATEST DEAL AMOUNT
$192M TOTAL AMOUNT RAISED
Description

Developer of a water-soluble drug designed to treat solid tumors. The company's Talaporfin Sodium drug is a water-soluble drug targeted by a small, single-use and disposable drug activator, enabling patients to get repeatable treatments.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Drug Discovery
Primary Office
12600 South East 38th Street
Suite 111
Bellevue, WA 98006
United States

+1 (425) 957-8900
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Light Sciences Oncology’s full profile, request a free trial.

Light Sciences Oncology Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 20-Dec-2013 $350k $192M Completed Generating Revenue
8. Later Stage VC 23-Jan-2012 00.000 00000 Completed Generating Revenue
7. Grant 02-Nov-2010 00000 00000 Completed Generating Revenue
6. Convertible Debt 05-Nov-2009 000.00 00000 Completed Generating Revenue
5. Later Stage VC (Series C) 16-Jul-2008 000.00 00000 Completed Generating Revenue
4. IPO 08-Feb-2008 000.00 Cancelled Generating Revenue
3. Senior Debt 31-Dec-2007 0000 00000 Completed Generating Revenue
2. Later Stage VC (Series B) 11-Jul-2007 $30M $100M Completed Generating Revenue
1. Later Stage VC (Series A) 14-Dec-2005 $70M $70M $94.4M Completed Generating Revenue
To view this company’s complete deal history including valuation and funding request access »

Light Sciences Oncology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00 00 00 00.000
To view this company’s complete Cap Table request access »

Light Sciences Oncology Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Adams Street Partners PE/Buyout Minority 000 0000 000000 0
Burrill & Co Merchant Banking Firm Minority 000 0000 000000 0
CDIB Capital Group Venture Capital Minority 000 0000 000000 0
Deephaven Capital Management Venture Capital Minority 000 0000 000000 0
EW Healthcare Partners Growth/Expansion Minority 000 0000 000000 0
You’re viewing 5 of 18 investors. Get the full list »

Light Sciences Oncology Executive Team (6)

Name Title Board
Seat
Contact
Info
Jim Chen Chief Strategy Officer & Co-Founder
Carol Schaaf Chief Revenue Officer & CRA
Richard Graves Director, Information Technology
Susan Spraitzar Senior Director, Regulatory Affairs
Steven Daly Senior Director, Strategy and Business Development
You’re viewing 5 of 6 executives. Get the full list »

Light Sciences Oncology Board Members (11)

Name Representing Role Since Contact
Info
Akbar Seddigh Self Board Member 000 0000
David Holveck Self Board Member 000 0000
Dennis Langer MD Self Board Member 000 0000
Elisha Gould Adams Street Partners Board Member 000 0000
Jeffrey Himawan Ph.D EW Healthcare Partners Board Member 000 0000

3 Former Board Members

You’re viewing 5 of 11 board members. Get the full list »